RE:Novo Nordisk buys Inversago PharmaIt's making headlines here in La Presse newspaper. As the article states, Inversago is the third Quebec's biotech bought for over a billion US in the last two years. They call the Inversago deal another homerun. Use Google traslate to read it in english. At the same time Thera's market cap is 40 M$ US.
The only optimism you can get out of these stories of buyouts, is that it's possible to turn things around. Thera did it in 2018, but it was a mirage, from a peak of 54 $ CAN per share to now 2 $ and Levesque was supposed to be such an upgrade at CEO...
https://www.lapresse.ca/affaires/chroniques/2023-08-11/un-autre-coup-de-circuit-par-une-biotech-quebecoise.php
jfm1330 wrote: You want to depress a little more about Thera ? Today a news came out that Novo Nordisk was buying Invesago Pharma, a drug development company based in Montreal. The founder of this company is Francois Ravenelle. He started it after he left Thera in the John Huss era. He was not even a V-P at Thera, just a director or something like that. So in about 10 years this bright guy was able to build a company that is now acquired by a big pharma for up to 1.075 billions US. This guy should have been V-P of pharmaceutical development at Thera, then the CEO.